Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells

Immunotherapy given before surgery caused liver cancer tumors to die off in one-third of the patients enrolled in a first-of-its-kind clinical trial

Related Keywords

Miriam Merad ,Thomas Marron ,Human Immune Monitoring Center ,Icahn School Of Medicine At Mount Sinai ,Tisch Cancer Institute ,Precision Immunology Institute ,Adjuvant Research Group To Evaluate Therapeutics ,Mount Sinai ,Lancet Gastroenterology ,Early Phase Trials Unit ,Associate Professor ,Medical Oncology ,Icahn School ,Adjuvant Research Group ,Evaluate Therapeutics ,Icahn Mount ,